Expression of class III ?-tubulin reduces microtubule assembly and confers resistance to paclitaxel
✍ Scribed by Hari, Malathi ;Yang, Hailing ;Zeng, Changqing ;Canizales, Martin ;Cabral, Fernando
- Book ID
- 102100296
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 317 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0886-1544
- DOI
- 10.1002/cm.10132
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Human brain and testis specific βIII‐tubulin was amplified from a cDNA library, modified to encode a C‐terminal hemagglutinin antigen epitope tag, and cloned into a vector that allows tetracycline regulated expression in mammalian cells. Immunofluorescence analysis of transfected Chinese hamster ovary cells demonstrated that expressed HA‐tagged βIII‐tubulin is able to assemble with endogenous tubulin into microtubules even though βIII‐tubulin is not a normal constituent of these cells. A stable G418‐resistant clone with moderate HAβIII‐tubulin expression displayed weak (1.5–2‐fold) resistance to paclitaxel. A second clone with higher HAβIII‐tubulin expression could not grow unless tetracycline was present to repress transcription of the transfected cDNA. Analysis of cellular microtubules in each of these clones indicated that incorporation of HAβIII‐tubulin led to a significant expression‐dependent decrease in assembled tubulin. Paclitaxel resistant cells were also directly selected from the transfected cell population using a paclitaxel concentration 4 times higher than the minimum toxic dose. Few cells were able to survive the selection and they grew very slowly. Western blot analysis of these resistant cells revealed very high HAβIII‐tubulin expression that led to almost complete replacement of endogenous β‐tubulin at steady state. Transfected βIII‐tubulin with no epitope tag behaved in a very similar fashion indicating that presence of the HA tag had no discernible functional effect. The results demonstrate that βIII‐tubulin diminishes microtubule assembly, is toxic when present at high levels, but is able to confer weak resistance to paclitaxel when expressed at moderate levels in mammalian cells. Cell Motil. Cytoskeleton 56:45–56, 2003. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
The expression of different protein kinase C (PKC) isoenzymes has been shown to vary with proliferation rates, differentiation or apoptosis in normal colon crypts. In addition, the activity of some PKC isoenzymes appears to be reduced in colorectal cancer. The aim of the present work was to determin